Abacavir/Dolutegravir/Lamivudine (Triumeq)–Induced Liver Toxicity in a Human Immunodeficiency Virus–Infected Patient-Reference-Cited by-同舟云学术

Abacavir/Dolutegravir/Lamivudine (Triumeq)–Induced Liver Toxicity in a Human Immunodeficiency Virus–Infected Patient

Published:2017 Issue:3 Volume:4 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Christensen Erin S.¹,Jain Rupali¹,Roxby Alison C.²

Affiliation:

1. Department of Pharmacy Services, and

2. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle

Abstract

Abstract Drug-induced liver injury related to Triumeq (abacavir/lamivudine/dolutegravir) has not been reported in clinical trials. We report a case of hepatotoxicity related to Triumeq exposure in a human immunodeficiency virus–infected patient. Clinicians should remain aware of the risk for acute and late-onset hepatitis with these agents. Close monitoring is recommended.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/4/3/ofx122/33622652/ofx122.pdf

Reference10 articles.

1. Antiretroviral drugs and liver injury;Soriano;AIDS,2008

2. Hepatoxicity of new antiretrovirals: a systematic review;Surgers;Clin Res Hepatol Gastroenterol,2013

3. A method for estimating the probability of adverse drug reactions;Naranjo;Clin Pharmacol Ther,1981

4. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity;Núñez;Hepatology,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moringa oleifera Lam Leaf Extract Stimulates NRF2 and Attenuates ARV-Induced Toxicity in Human Liver Cells (HepG2);Plants;2023-04-03

2. The Potential of Moringa oleifera to Ameliorate HAART-Induced Pathophysiological Complications;Cells;2022-09-24

3. HIV and liver disease;Aids Reviews;2022-06-28

4. Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors;AIDS;2021-11-01

5. Hepatotoxicity of contemporary antiretroviral drugs;Current Opinion in HIV and AIDS;2021-09-20